4//SEC Filing
Woerle Hans-Juergen 4
Accession 0000950170-25-015020
CIK 0001609809other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 8:05 AM ET
Size
5.3 KB
Accession
0000950170-25-015020
Insider Transaction Report
Form 4
Woerle Hans-Juergen
Director
Transactions
- Award
Stock Option (right to buy)
2025-02-04+120,000→ 120,000 totalExercise: $0.81Exp: 2035-02-03→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The option will vest in four substantially equal installments on each anniversary of February 4, 2025 or in full immediately prior to the occurrence of a change in control.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0002046489
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 8:05 AM ET
- Size
- 5.3 KB